Laser Hair Removal on Darker Skin: Why Wavelength Matters
Darker skin is not a blanket reason to avoid laser — it is a reason to choose wavelength, settings and operator carefully.
Yes, laser hair removal can be suitable for darker skin. The important issue is the margin between heating pigment in the hair and heating melanin in the surrounding skin. A longer 1064 nm Nd:YAG wavelength is often selected for higher Fitzpatrick skin types because epidermal melanin absorbs it less strongly than shorter wavelengths.
Hair pigment and skin pigment compete for energy
Laser hair reduction relies on melanin in the hair shaft and follicle absorbing light and converting it to heat. Darker skin contains more epidermal melanin, so there is less room for error between an effective follicle dose and unwanted heating of the skin. This is why skin tone must be assessed alongside current tan, hair colour, hair thickness, body area and recent sun exposure.
Safety does not come from a wavelength name alone. Pulse duration, fluence, cooling, spot size, technique and the experience of the person selecting the settings all matter. A patch test helps assess an individual response but cannot guarantee that every later treatment will behave identically.
Nd:YAG creates a wider epidermal safety margin
In a randomized, within-patient trial involving Fitzpatrick IV–VI skin, five long-pulsed 1064 nm Nd:YAG sessions produced a larger hair-count reduction at six months than IPL in the tested axillae. Temporary inflammation and higher pain scores occurred, which is an important reminder that “safer for darker skin” does not mean sensation-free or risk-free.
Longer wavelengths penetrate more deeply and are less avidly absorbed by surface melanin. That makes Nd:YAG a valuable option for darker or recently pigmented skin, although an active tan can still narrow the treatment window enough that postponing is the safer decision.
755 nm can be powerful, but it is not automatically the right choice
Alexandrite at 755 nm is strongly absorbed by melanin and can be highly effective where there is good contrast between dark hair and lighter, untanned skin. A recent split-body study in Fitzpatrick II–III participants found single 755 nm treatment outperformed a particular blended 755/1064 protocol for axillary reduction. That result should not be generalized to darker phototypes, a different device or different settings.
Blended 755/1064 approaches may help selected “challenging” combinations of skin and hair. A randomized study found a 70/30 Nd:YAG/Alexandrite blend tended to balance reduction, epidermal effects and discomfort in its tested group. The honest conclusion is not that one wavelength always wins; it is that wavelength selection should follow the person in front of the device.
What a good consultation should cover
- Which wavelength will be used for my current skin tone, and why?
- How will settings change if I tan or my skin changes between visits?
- What cooling and patch-test process is used?
- What reactions are expected, and what symptoms need urgent contact?
- Is my hair dark and coarse enough to be a useful target?
At Rejuvena, the Motus AY provides 755 nm Alexandrite and 1064 nm Nd:YAG options. The device choice supports individualized treatment; it does not remove the need for assessment and conservative clinical judgement.
Reviewed by Dr Nick
Dr Nick, Medical Director — GMC 6072251. This guide was clinically reviewed on 25 August 2026. It explains general evidence and cannot replace an assessment of your skin, hair, medicines and medical history.
Research used for this guide
- Long-pulsed Nd:YAG laser vs intense pulsed light for hair removal in dark skin — randomized controlled trial in Fitzpatrick IV–VI skin
- Hair removal with blended 755/1064 nm laser energy — prospective randomized study of blended wavelength ratios
- Single 755 nm versus dual 755/1064 nm hair removal — split-body blinded study in Fitzpatrick II–III participants
- Laser-assisted hair removal side effects across three systems — 900-treatment review highlighting tan, skin type and parameter selection
Study protocols, devices and patient groups differ. Percentages from one trial should not be read as a personal result guarantee.